Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ViroPharma acquires option to acquire Meritage; Shire later exercises option for up to $245mm

Executive Summary

Rare disease drug developer ViroPharma Inc. has received the exclusive option to acquire privately held GI-focused Meritage Pharma Inc. in exchange for $7.5mm up front, plus up to $12.5mm in option milestones based on the attainment of certain clinical development and regulatory goals.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Payment Includes Cash
    • Full Acquisition
    • Acquisition of Private Biotech
    • Intra-Biotech Deal

Related Companies